{"id":"NCT01815736","sponsor":"Gilead Sciences","briefTitle":"Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants","officialTitle":"A Phase 3, Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-03-27","primaryCompletion":"2015-03-16","completion":"2020-04-01","firstPosted":"2013-03-21","resultsPosted":"2016-04-14","lastUpdate":"2021-04-13"},"enrollment":1443,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["HIV","HIV Infections"],"interventions":[{"type":"DRUG","name":"E/C/F/TAF","otherNames":["EVG/COBI/FTC/TAF; Genvoya®"]},{"type":"DRUG","name":"E/C/F/TDF","otherNames":["Stribild®"]},{"type":"DRUG","name":"EFV/FTC/TDF","otherNames":["Atripla®"]},{"type":"DRUG","name":"RTV","otherNames":["Norvir®"]},{"type":"DRUG","name":"ATV","otherNames":["Reyataz®"]},{"type":"DRUG","name":"FTC/TDF","otherNames":["Truvada®"]},{"type":"DRUG","name":"COBI","otherNames":["Tybost®","GS-9350"]}],"arms":[{"label":"E/C/F/TAF","type":"EXPERIMENTAL"},{"label":"Stay on Baseline Treatment Regimen (SBR)","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective of this study is to evaluate the non-inferiority of switching to a tenofovir alafenamide (TAF)-containing fixed dose combination (FDC) relative to maintaining tenofovir disoproxil fumarate (TDF)-containing combination regimens in virologically suppressed HIV-infected participants as determined by having HIV-1 RNA \\< 50 copies/mL at Week 48.","primaryOutcome":{"measure":"Percentage of Participants With HIV-1 RNA < 50 Copies/mL at Week 48","timeFrame":"Week 48","effectByArm":[{"arm":"E/C/F/TAF","deltaMin":95.6,"sd":null},{"arm":"Stay on Baseline Treatment Regimen (SBR)","deltaMin":92.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.051"},{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":13,"exclusionCount":13},"locations":{"siteCount":167,"countries":["United States","Australia","Austria","Belgium","Brazil","Canada","Denmark","Dominican Republic","France","Germany","Italy","Mexico","Netherlands","Portugal","Puerto Rico","Spain","Sweden","Switzerland","Thailand","United Kingdom"]},"refs":{"pmids":["26538525","28259777","30932951","31826005","31303140","29368537"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":79,"n":959},"commonTop":["Upper respiratory tract infection","Diarrhoea","Nasopharyngitis","Cough","Back pain"]}}